A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs

Systematically identifying synergistic combinations of targeted agents and immunotherapies for cancer treatments remains difficult. In this study, we integrated high-throughput and high-content techniques—an implantable microdevice to administer multiple drugs into different sites in tumors at nanod...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatarova, Zuzana, Blumberg, Dylan C., Korkola, James E., Heiser, Laura M., Muschler, John L., Schedin, Pepper J., Ahn, Sebastian W., Mills, Gordon B., Coussens, Lisa M., Jonas, Oliver, Gray, Joe W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750874/
https://www.ncbi.nlm.nih.gov/pubmed/35788566
http://dx.doi.org/10.1038/s41587-022-01379-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750874/
https://www.ncbi.nlm.nih.gov/pubmed/35788566
http://dx.doi.org/10.1038/s41587-022-01379-y

Ejemplares similares